SEPTANEST

This brand name is authorized in Austria, Canada, Croatia, Cyprus, Ecuador, Estonia, France, Hong Kong SAR China, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, South Africa, Spain, Tunisia, UK.

Active ingredients

The drug SEPTANEST contains a combination of these active pharmaceutical ingredients (APIs):

1	Articaine UNII QS9014Q792 - ARTICAINE HYDROCHLORIDE
	Articaine is a local anaesthetic of the amide type. Preclinical pharmacodynamic studies show that the mechanism of action of articaine is similar to that of other commonly used anaesthetics.
	Read more about Articaine
2	Epinephrine UNII 30Q7KI53AK - EPINEPHRINE BITARTRATE
	Epinephrine is a direct acting sympathomimetic agent, which exerts effects on both α and β adrenoceptors. It has more pronounced effects on β than on α adrenoceptors, although α effects prevail at high doses. The effects of adrenaline include increased rate and force of cardiac contraction, cutaneous vasoconstriction and broncho-dilatation.
	Read more about Epinephrine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N01BB58	Articaine, combinations	N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB58

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02123371, 02123398
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	23.384-1-05-11, 360390512
EE	Ravimiamet	1010967, 1010978, 1818176, 1818187, 1818198, 1818200
ES	Centro de información online de medicamentos de la AEMPS	59941, 59942
FR	Base de données publique des médicaments	60484221, 69208046
GB	Medicines & Healthcare Products Regulatory Agency	211428, 326399
HK	Department of Health Drug Office	58946
HR	Agencija za lijekove i medicinske proizvode	HR-H-142112354, HR-H-649485270
LT	Valstybinė vaistų kontrolės tarnyba	1012964, 1089456, 1089457, 1089458, 1089459, 1089460, 1089461
MT	Medicines Authority	MA035/00201, MA035/00202
NL	Z-Index G-Standaard	14785196, 14785218
NL	Z-Index G-Standaard, PRK	145890, 145904
NZ	Medicines and Medical Devices Safety Authority	11837, 21325, 21504
PL	Rejestru Produktów Leczniczych	100060602, 100060619
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W05650001, W05650002, W05650003, W05650004, W10707001, W10707002, W10707003, W10707004
TN	Direction de la Pharmacie et du Médicament	8533013, 8533014
ZA	Health Products Regulatory Authority	A38/4/0412